Democratising Drug Discovery – Widening Access to Expertise and Technologies

Wed20  Oct02:30pm(30 mins)
Room 3B
Prof Peter Simpson


Drug Discovery is dependent upon great new ideas but needs access to specialist know-how and technologies to ensure projects advance to go-no go decisions with pace. Many UK SMEs are <5 people, so need to be supported on their journey by partnerships with providers and holders of technologies, data, tools and expertise. Medicines Discovery Catapult is a UK not-for-profit company which has created a suite of capabilities, that can be deployed into drug discovery programmes to ensure informative decision-making assay cascades and development plans. MDC is also positioned to create long term value through partnership models access research charities, academia, CROs and biotechs. Several examples will be discussed on how MDC has made their otherwise difficult-to-access expertise and technologies accessible, to inform decision making and support UK innovators towards success.
LinkedIn details
To view the video assoicated with this lecture click here

Hosted By

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Event Logo Find us on Facebook Follow us on Twitter

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG,, Labhoo Ltd 2003-2021